Lu et al. recently reported that IRF6 is downregulated in glioma, with the Lin28A/SNHG14/IRF6 axis reprogramming glucose metabolism and stimulating tumorigenesis in glioma cells [13]. Here, IRF6 is linked to central nervous system cancer.